Search by Drug Name or NDC

    NDC 60505-0142-00 Glipizide 10 mg/1 Details

    Glipizide 10 mg/1

    Glipizide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Apotex Corp.. The primary component is GLIPIZIDE.

    Product Information

    NDC 60505-0142
    Product ID 60505-0142_74c771a5-d24d-4efe-8b7d-7af899581728
    Associated GPIs 27200030000310
    GCN Sequence Number 001776
    GCN Sequence Number Description glipizide TABLET 10 MG ORAL
    HIC3 C4K
    HIC3 Description ANTIHYPERGLYCEMIC, INSULIN-RELEASE STIMULANT TYPE
    GCN 10841
    HICL Sequence Number 000803
    HICL Sequence Number Description GLIPIZIDE
    Brand/Generic Generic
    Proprietary Name Glipizide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Glipizide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 10
    Active Ingredient Units mg/1
    Substance Name GLIPIZIDE
    Labeler Name Apotex Corp.
    Pharmaceutical Class Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA075795
    Listing Certified Through 2024-12-31

    Package

    NDC 60505-0142-00 (60505014200)

    NDC Package Code 60505-0142-0
    Billing NDC 60505014200
    Package 100 TABLET in 1 BOTTLE (60505-0142-0)
    Marketing Start Date 2002-09-25
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.04912
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description GLIPIZIDE 10 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis